5/9/2013 6:40:08 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
REDWOOD CITY, Calif., May 8, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the first quarter ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by